Titelia

Holdings of Soleus Capital Management, L.P.

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
82 in 3 countries
Top ten
55.3 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Krystal Biotech Inc 1,153,087297.9M $
2Celcuity Inc 1,284,378146.6M $
3TG Therapeutics Inc 4,029,319133.9M $
4Insulet Corp 562,500118M $
5United Therapeutics Corp 187,187111M $
6Praxis Precision Medicines Inc 330,517106.5M $
7Vericel Corp 2,549,07982M $
8ANI Pharmaceuticals Inc 820,24363.1M $
9Globus Medical Inc 729,46762.9M $
10Geron Corp 41,508,65961.8M $
11Twist Bioscience Corp 1,226,62958.3M $
12Edgewise Therapeutics Inc 1,449,91545.7M $
13Beta Bionics Inc 4,354,50143.6M $
14Alnylam Pharmaceuticals Inc 131,65043.6M $
15Syndax Pharmaceuticals Inc 1,726,90840.3M $
16Indivior Pharmaceuticals Inc 1,274,00038.8M $
17NeuroPace Inc 2,932,20738.6M $
18Mirum Pharmaceuticals Inc 400,30637M $
19BioMarin Pharmaceutical Inc 650,57236.8M $
20Progyny Inc 2,067,00035.1M $
21Inspire Medical Systems Inc 576,29929.7M $
22Edap Tms SA 7,309,25427.2M $
23Merck & Co Inc 203,00024.4M $
24Organogenesis Holdings Inc 10,085,95123.9M $
25Natera Inc 119,00023.8M $
26Axogen Inc 679,17022.5M $
27Vaxcyte Inc 385,47222.4M $
28Cerus Corp 10,753,70019.6M $
29Trevi Therapeutics Inc 1,620,00019.3M $
30Inhibikase Therapeutics Inc 10,875,00018.3M $
31Context Therapeutics Inc 6,963,14118.2M $
32Vir Biotechnology Inc 2,002,00017.9M $
33Travere Therapeutics Inc 546,00016.2M $
34Tandem Diabetes Care Inc 783,00015M $
35Nurix Therapeutics Inc 938,16314.5M $
36Sionna Therapeutics Inc 293,50011.8M $
37Corcept Therapeutics Inc 285,53111.5M $
38JADE BIOSCIENCES INC 796,74411.2M $
39Veracyte Inc 319,91210.3M $
40Invivyd Inc 7,708,72710M $
41C4 Therapeutics Inc 3,803,94210M $
42OrthoPediatrics Corp 615,4479.8M $
43Arcus Biosciences Inc 451,9839.8M $
44Tango Therapeutics Inc 450,0009.4M $
45Evolus Inc 2,245,3609.2M $
46Enliven Therapeutics Inc 230,8699.1M $
47Inhibrx Biosciences Inc 131,0008.8M $
48Dexcom Inc 140,0008.8M $
49Septerna Inc 275,0006.6M $
50AVALO THERAPEUTICS INC 441,9786.6M $
51BIODESIX INC 416,5996M $
52Relmada Therapeutics Inc 842,1065.9M $
53Cullinan Therapeutics Inc 410,2005.8M $
54Immunovant Inc 230,0005.7M $
55MBX Biosciences Inc 178,8975.3M $
56IMMUNIC INC 4,500,0005M $
57Larimar Therapeutics Inc 1,066,9604.8M $
58Eton Pharmaceuticals Inc 166,3814.1M $
59SAB Biotherapeutics Inc 1,050,0004M $
60PROCEPT BIOROBOTICS CORP 160,0004M $
61Structure Therapeutics Inc 80,0003.9M $
62Tectonic Therapeutic Inc 121,6843.8M $
63Pulmonx Corp 2,788,3233.6M $
64Iovance Biotherapeutics Inc 1,000,0003.5M $
65Argenx SE 3,5002.6M $
66Karyopharm Therapeutics Inc 440,0002.5M $
67Arrowhead Pharmaceuticals Inc 28,4791.8M $
68InspireMD, Inc. 1,045,7081.7M $
69Insmed Inc 10,2501.7M $
70CytomX Therapeutics Inc 300,0001.4M $
71CG oncology Inc 20,0001.4M $
72NeoGenomics Inc 175,0001.3M $
73Cogent Biosciences Inc 10,000384.9K $
74Tyra Biosciences Inc 10,000383K $
75STAAR Surgical Co 20,000374K $
76AnaptysBio Inc 6,000332.8K $
77Rapport Therapeutics Inc 10,000312.9K $
78Rigel Pharmaceuticals Inc 10,000270.4K $
79Zymeworks Inc 10,000250.4K $
80LB Pharmaceuticals Inc 10,000246.6K $
81Oruka Therapeutics Inc 5,000245.3K $
82JASPER THERAPEUTICS INC 276,312242.1K $

Download this table: CSV, JSON

Sector breakdown

  • Health care 10.1 %
  • Unattributed 89.9 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 98.6 %
  • France 1.3 %
  • Netherlands 0.1 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States802.1B $98.61 %
2France127.2M $1.27 %
3Netherlands12.6M $0.12 %
Cite this page

Titelia. "Holdings of Soleus Capital Management, L.P.". https://titelia.com/en/funds/US13F1802630